Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D De Jongh

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 24, 2021
Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating proceduresJaap N E Bakers, Adriaan D de Jongh, Tommy M Bunte, et al.
Neurology|June 13, 2023
Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALSAdriaan D de Jongh, Ruben P A van Eijk, Leonhard A Bakker, et al.
Neurology|January 21, 2021
Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the NetherlandsAdriaan D de Jongh, Ruben P A van Eijk, Susan M Peters, et al.
Neurology|July 28, 2021
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established OrderRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 24, 2021
Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating proceduresJaap N E Bakers, Adriaan D de Jongh, Tommy M Bunte, et al.
Neurology|June 13, 2023
Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALSAdriaan D de Jongh, Ruben P A van Eijk, Leonhard A Bakker, et al.
Neurology|January 21, 2021
Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the NetherlandsAdriaan D de Jongh, Ruben P A van Eijk, Susan M Peters, et al.
Neurology|July 28, 2021
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established OrderRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
Pageof 2